CO6480960A2 - Composiciones solidas que comprenden ácido 5- aminolevulinico - Google Patents
Composiciones solidas que comprenden ácido 5- aminolevulinicoInfo
- Publication number
- CO6480960A2 CO6480960A2 CO11179486A CO11179486A CO6480960A2 CO 6480960 A2 CO6480960 A2 CO 6480960A2 CO 11179486 A CO11179486 A CO 11179486A CO 11179486 A CO11179486 A CO 11179486A CO 6480960 A2 CO6480960 A2 CO 6480960A2
- Authority
- CO
- Colombia
- Prior art keywords
- solid
- solid compositions
- precancerous
- ala
- cancer
- Prior art date
Links
- 239000008247 solid mixture Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 239000007787 solid Substances 0.000 abstract 4
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical group NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 229960002749 aminolevulinic acid Drugs 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 229940127557 pharmaceutical product Drugs 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000005095 gastrointestinal system Anatomy 0.000 abstract 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09251538 | 2009-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6480960A2 true CO6480960A2 (es) | 2012-07-16 |
Family
ID=42628133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO11179486A CO6480960A2 (es) | 2009-06-11 | 2011-12-27 | Composiciones solidas que comprenden ácido 5- aminolevulinico |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20120134921A1 (enExample) |
| EP (1) | EP2440188A1 (enExample) |
| JP (1) | JP2012529451A (enExample) |
| KR (1) | KR20140014401A (enExample) |
| CN (1) | CN102802612A (enExample) |
| AU (1) | AU2010257752B2 (enExample) |
| BR (1) | BRPI1011650A2 (enExample) |
| CA (1) | CA2763837A1 (enExample) |
| CL (1) | CL2011003115A1 (enExample) |
| CO (1) | CO6480960A2 (enExample) |
| CR (1) | CR20110649A (enExample) |
| MX (1) | MX2011013069A (enExample) |
| NZ (1) | NZ596946A (enExample) |
| PE (1) | PE20120858A1 (enExample) |
| RU (1) | RU2527328C2 (enExample) |
| SG (1) | SG176687A1 (enExample) |
| WO (1) | WO2010142456A1 (enExample) |
| ZA (1) | ZA201108850B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013521251A (ja) * | 2010-03-01 | 2013-06-10 | フォトキュア エイエスエイ | 美容組成物 |
| DE102012105512A1 (de) * | 2012-06-25 | 2014-04-24 | Hennig Arzneimittel Gmbh & Co. Kg | Arzneiform zur verlängerten Freisetzung von Wirkstoffen |
| US20140067024A1 (en) | 2012-08-30 | 2014-03-06 | Photocure Asa | Dual panel photodynamic therapy lamp |
| GB201221123D0 (en) | 2012-11-23 | 2013-01-09 | Photocure As | Device for photodynamic treatment |
| KR20150141958A (ko) * | 2013-03-12 | 2015-12-21 | 어플라이드 바이오리서치, 인크. | 개선된 약물 전달을 위한 킬레이트화 좌제 |
| JP6588193B2 (ja) * | 2014-07-31 | 2019-10-09 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌ Ｂｅｌｇｉｕｍ ＮＶ | カプセル製剤 |
| US20170216146A1 (en) * | 2014-07-31 | 2017-08-03 | Capsugel Belgium Nv | Capsule formulation |
| US11623008B2 (en) * | 2014-08-20 | 2023-04-11 | Professional Compounding Centers Of America | Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan |
| US9956426B2 (en) | 2015-02-26 | 2018-05-01 | Amol Punjabi | Upconverting nanoparticles |
| AU2016372575B2 (en) | 2015-12-17 | 2022-12-08 | Photocure Asa | Method of photodynamic therapy (PDT) for bladder cancer |
| GB201522398D0 (en) | 2015-12-18 | 2016-02-03 | Photocure As | Device for photodynamic therapy |
| CN105481946B (zh) * | 2015-12-18 | 2019-05-21 | 浙江工商大学 | 5-氨基酮戊酸与3-羟基吡啶-4-酮的缀合物及其制备法和用途 |
| US10744212B2 (en) | 2016-03-14 | 2020-08-18 | General Electric Company | Topical application of nerve labeling dyes for image-guided surgery |
| GB2546128A (en) * | 2016-09-28 | 2017-07-12 | Photocure Asa | Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same |
| JP7136807B2 (ja) | 2017-04-17 | 2022-09-13 | ザ・ユニバーシティ・オブ・シカゴ | ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料 |
| CN107434753A (zh) * | 2017-07-26 | 2017-12-05 | 南京大学 | 5‑氨基乙酰丙酸及其衍生物的泡腾片及其制备方法 |
| PH12020550124B1 (en) | 2017-12-01 | 2024-05-24 | Nat Ct Child Health & Dev | Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3181062B2 (ja) * | 1991-01-31 | 2001-07-03 | 帝國製薬株式会社 | 下部消化管崩壊経口製剤 |
| US6492420B2 (en) * | 1995-03-10 | 2002-12-10 | Photocure As | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| CZ291132B6 (cs) * | 1995-03-10 | 2002-12-11 | Photocure Asa | Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem |
| EP2127642A3 (en) * | 1998-08-13 | 2010-02-24 | Cima Labs, Inc. | Microemulsions as solid dosage forms for oral administration |
| EP1184038B1 (en) * | 1999-06-09 | 2005-12-28 | Mochida Pharmaceutical Co., Ltd. | System for release in lower digestive tract |
| DE10003620A1 (de) * | 2000-01-28 | 2001-08-02 | Asat Ag Applied Science & Tech | 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln |
| GB0018527D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Composition |
| GB0018528D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Compounds |
| US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| US7264629B2 (en) * | 2001-11-09 | 2007-09-04 | Qlt, Inc. | Photodynamic therapy for the treatment of hair loss |
| TW577606U (en) * | 2001-11-20 | 2004-02-21 | Carry Computer Eng Co Ltd | Improved structure of all-in-one silicon disk |
| DE102005019628A1 (de) * | 2005-04-26 | 2006-11-09 | Technische Universität Braunschweig | Formulierung zur dermalen Anwendung |
| GB0609809D0 (en) * | 2006-05-17 | 2006-06-28 | Photocure Asa | Product |
| GB0724279D0 (en) * | 2007-12-12 | 2008-01-23 | Photocure Asa | Use |
-
2010
- 2010-06-11 CN CN2010800256075A patent/CN102802612A/zh active Pending
- 2010-06-11 NZ NZ596946A patent/NZ596946A/en not_active IP Right Cessation
- 2010-06-11 WO PCT/EP2010/003531 patent/WO2010142456A1/en not_active Ceased
- 2010-06-11 PE PE2011002072A patent/PE20120858A1/es not_active Application Discontinuation
- 2010-06-11 CA CA2763837A patent/CA2763837A1/en not_active Abandoned
- 2010-06-11 SG SG2011090040A patent/SG176687A1/en unknown
- 2010-06-11 AU AU2010257752A patent/AU2010257752B2/en not_active Expired - Fee Related
- 2010-06-11 US US13/377,692 patent/US20120134921A1/en not_active Abandoned
- 2010-06-11 RU RU2011150920/15A patent/RU2527328C2/ru not_active IP Right Cessation
- 2010-06-11 KR KR1020117030694A patent/KR20140014401A/ko not_active Withdrawn
- 2010-06-11 MX MX2011013069A patent/MX2011013069A/es not_active Application Discontinuation
- 2010-06-11 BR BRPI1011650A patent/BRPI1011650A2/pt not_active IP Right Cessation
- 2010-06-11 JP JP2012514392A patent/JP2012529451A/ja not_active Ceased
- 2010-06-11 EP EP10725043A patent/EP2440188A1/en not_active Withdrawn
-
2011
- 2011-12-01 ZA ZA2011/08850A patent/ZA201108850B/en unknown
- 2011-12-05 CR CR20110649A patent/CR20110649A/es unknown
- 2011-12-07 CL CL2011003115A patent/CL2011003115A1/es unknown
- 2011-12-27 CO CO11179486A patent/CO6480960A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20120134921A1 (en) | 2012-05-31 |
| AU2010257752B2 (en) | 2015-04-09 |
| ZA201108850B (en) | 2013-02-27 |
| RU2011150920A (ru) | 2013-07-20 |
| NZ596946A (en) | 2014-07-25 |
| EP2440188A1 (en) | 2012-04-18 |
| CN102802612A (zh) | 2012-11-28 |
| CR20110649A (es) | 2012-03-22 |
| RU2527328C2 (ru) | 2014-08-27 |
| PE20120858A1 (es) | 2012-08-01 |
| JP2012529451A (ja) | 2012-11-22 |
| AU2010257752A1 (en) | 2012-01-12 |
| WO2010142456A1 (en) | 2010-12-16 |
| SG176687A1 (en) | 2012-01-30 |
| BRPI1011650A2 (pt) | 2016-03-22 |
| CA2763837A1 (en) | 2010-12-16 |
| CL2011003115A1 (es) | 2012-06-22 |
| MX2011013069A (es) | 2012-02-01 |
| KR20140014401A (ko) | 2014-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6480960A2 (es) | Composiciones solidas que comprenden ácido 5- aminolevulinico | |
| ES2409069B2 (es) | Uso de aglutinantes para fabricar formulaciones estables al almacenamiento | |
| CY1121107T1 (el) | Φαρμακοτεχνικες μορφες δισκιων αμεσης απελευθερωσης | |
| ES2488407T3 (es) | Preparación farmacéutica que contiene lipasa de origen bacteriano | |
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| CO6480932A2 (es) | Antagonistas de la trayectoria hedgehog de ftalazina disustituida. | |
| CL2009002073A1 (es) | Composicion farmaceutica solida para la liberacion controlada de un agente activo activo en el tracto gastrointestinal que comprende al menos un agente acido con solubilidad de menos de 0,3 mg/ml en solucion acuosa a un ph alrededor del pka del agente acido, un polimero hidrofilo, un alcanizador; uso en trastornos cardiovasculares. | |
| BR112015000106A2 (pt) | moduladores heterocíclicos de síntes de lipídio | |
| AR080491A1 (es) | Formulaciones orales y sales lipofilicas de metilnaltrexona | |
| ECSP088414A (es) | Derivados de ácido bifeniloxiacético para el tratamiento de una enfermedad respiratoria | |
| UA105229C2 (uk) | Фармацевтичний склад | |
| UY32487A (es) | Composiciones farmacéuticas de liberación inmediata comprendiendo oxicodona y naloxona | |
| NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
| CY1118032T1 (el) | Διεργασιες για την εμπορικη παρασκευη φαρμακευτικα δραστικου παραγοντα | |
| AR069211A1 (es) | Derivados de acidos de 1,2,4-oxadiazol ciclobutanoamino carboxilicos, una composicion farmaceutica, proceso de preparacion del compuesto y su uso para preparar medicamentos | |
| CR20150266A (es) | Formulaciones de liberación modificada para oprozomib | |
| BR112013000613A2 (pt) | composições secas e dispositivos que contêm tais composições secas | |
| BR112014032620A2 (pt) | conjugado de nsaid-polímero | |
| EA201270745A1 (ru) | Улучшенный стабильный водный состав (e)-4-карбоксистирил-4-хлорбензилсульфона | |
| ECSP088988A (es) | Derivados de ácido fenilacético | |
| CO6592037A2 (es) | Combinación de un aine y un aminoacido | |
| CY1119692T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει (1r,4r)-6'-φθορο-ν,ν-διμεθυλ-4-φαινυλ-4',9'-διυδρο-3ή-σπιρο [κυκλο-εξανο-1,1'-πυρανο-(3,4,b)ινδολ)-αμινη και ακετυλο-σαλικυλικο οξυ | |
| MX2010012927A (es) | Una mezcla solubilizante, solucion farmaceutica para tratar otitis y su metodo de preparacion. | |
| TH111755A (th) | ไทรอะโซโลพิริดาซีนในรูปสารยับยั้ง par 1, การเตรียมของสารเหล่านั้นและการใช้สารเหล่านั้นเป็นยา | |
| TH160178A (th) | องค์ประกอบทางเภสัชกรรมที่ประกอบด้วยอะโปมอร์ฟีน (apomorphine) ในฐานะเป็นส่วนผสมออกฤทธิ์ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |